SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Globalisation

Continued biopharma growth for Pall

By Natalie Morrison , 13-Sep-2012
Last updated on 13-Sep-2012 at 12:43 GMT

Pall Corporation has once again hailed its biopharma consumables business a key factor in its sales growth.

The firm – which reported an overall 5.9 per cent increase in revenues for its fiscal fourth quarter – said the contribution from its pharmaceutical business rose to $218m from $200m in the comparable period in fiscal 2011. 

Continued strength in the biotechnology market was one reason for the uptick the company said, especially for consumables which pulled in 21 per cent more sales compared with 2011.

Pall said this was partly due to the BLItz and Octet label-free protein analysis instrumentation platforms, which it acquired last December with its takeover of Californian firm ForteBio . Laboratory consumables sales also grew.

Larry Kingsley, president and CEO, said: “We executed a solid fourth quarter. We focused almost exclusively on restoring customer service levels”

Systems sales

But, while strong drug industry demand for certain services and technologies - primarily consumables - drove growth in Q4 other part of Pall's biopharmaceuticals business suffered, notably processing systems which saw sales decline 22 per cent.

In his commentary Kingsley said: "System sales were negative in the quarter as a function of a very large comparison quarter in FY11, our decision to pare certain unprofitable system sales, and lower capital commitment in some markets."

The decline in systems revenue - which was also seen in Pall's food an beverage businesses - is not the first it has reported this year. In the fiscal third quarter, systems sales were down 60 per cent, though this was largely put down to the team dealing with problems at its then-new enterprise resource planning unit (ERP).

In its latest results Pall said it has “recovered from the ERP implementation challenges in the third quarter of FY12."

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Related products

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products

Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry